Gametocyte Dynamics and the Role of Drugs in Reducing the Transmission Potential of Plasmodium vivax
Background. Designing interventions that will reduce transmission of vivax malaria requires knowledge of Plasmodium vivax gametocyte dynamics.
Main Authors: | Douglas, Nicholas M., Simpson, Julie A., Phyo, Aung Pyae, Siswantoro, Hadjar, Hasugian, Armedy R., Kenangalem, Enny, Poespoprodjo, Jeanne Rini, Singhasivanon, Pratap, Anstey, Nicholas M., White, Nicholas J., Tjitra, Emiliana, Nosten, Francois, Price, Ric N. |
---|---|
Format: | Online |
Language: | English |
Published: |
Oxford University Press
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733516/ |
Similar Items
-
Dihydroartemisinin-Piperaquine Treatment of Multidrug Resistant Falciparum and Vivax Malaria in Pregnancy
by: Poespoprodjo, Jeanne Rini, et al.
Published: (2014) -
Plasmodium vivax infection: a major determinant of severe anaemia in infancy
by: Kenangalem, Enny, et al.
Published: (2016) -
Treatment policy change to dihydroartemisinin–piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes
by: Poespoprodjo, Jeanne Rini, et al.
Published: (2015) -
Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia
by: Karyana, Muhammad, et al.
Published: (2016) -
Dihydroartemisinin-Piperaquine Versus Chloroquine in the Treatment of Plasmodium vivax Malaria in Thailand: A Randomized Controlled Trial
by: Phyo, Aung Pyae, et al.
Published: (2011)